CHS — Comprehensive Healthcare Systems Income Statement
0.000.00%
Last trade - 00:00- CA$0.62m
- CA$3.62m
- $4.30m
Annual income statement for Comprehensive Healthcare Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 4.5 | 4.3 |
| Cost of Revenue | ||
| Gross Profit | 1.37 | 1.4 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Total Operating Expenses | 8.4 | 9.1 |
| Operating Profit | -3.91 | -4.79 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -4.93 | -5.11 |
| Net Income After Taxes | -4.93 | -5.11 |
| Net Income Before Extraordinary Items | ||
| Net Income | -4.93 | -5.11 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -4.93 | -5.11 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.116 | -0.075 |